Jannah Wardatul, Alfian Sofa D, Abdulah Rizky
Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Jatinangor, Indonesia.
Drug Utilization and Pharmacoepidemiology Research Group, Center of Excellence for Pharmaceutical Care Innovation, Universitas Padjadjaran, Jatinangor, Indonesia.
Int J Chron Obstruct Pulmon Dis. 2025 Apr 9;20:1009-1026. doi: 10.2147/COPD.S498302. eCollection 2025.
To identify psychosocial and sociodemographic factors influencing low medication awareness among patients with Chronic obstructive pulmonary disease (COPD) based on Indonesian Family Life Survey 5 (IFLS-5).
This study used a cross-sectional design, with data from IFLS-5 (2014/2015). Inclusion criteria were subjects with a self-reported diagnosis of COPD and aged at least 15 years. Two main factors were identified as modifiable psychosocial factors (eg, insomnia, depressive symptoms, happiness status, general health check status, smoking status, and health service satisfaction) and as non-modifiable sociodemographic factors (eg, gender, age, education level, marital status, economic status, insurance ownership, religiosity, comorbidity, and place of residence). Multivariate logistic regression analysis was used to explore the relationship between these factors and the awareness of COPD medication, by observing the adjusted odds ratio (aOR) within a 95% Confidence Interval.
There were 618 subjects identified with COPD, of which 53.40% were male. 84.30% of subjects have low medication awareness. Non-modifiable sociodemographic factors such as age 15-25 years (aOR: 2.531; 95% CI 1.024-6.253; p-value 0.044), age 26-35 years (aOR: 3.418; 95% CI 1.444-8.091; p-value 0.005), high school education level (aOR: 4.870; 95% CI 1.685-14.078; p-value 0.003), and modifiable psychosocial factors such as satisfaction with health services with the category "sufficient" (aOR: 2.510; 95% CI 510; 95% CI 1.508-4.176; p-value 0.000), and subjects who smoked (aOR: 1.894; 95% CI 1.147-3.127; p-value 0.013), were significantly associated with low COPD medication awareness.
This study shows that most subjects with COPD had low medication awareness, which is influenced by factors such as age, education level, smoking habits, and satisfaction with health services. This highlights the need for targeted interventions for high-risk groups. Limitations of this study include reliance on self-reported data, which may lead to recall bias. In addition, this study was unable to provide evidence of a causal relationship.
基于印度尼西亚家庭生活调查5（IFLS - 5），确定影响慢性阻塞性肺疾病（COPD）患者用药知晓率低的心理社会因素和社会人口学因素。
本研究采用横断面设计，数据来自IFLS - 5（2014/2015）。纳入标准为自我报告诊断为COPD且年龄至少15岁的受试者。确定了两个主要因素，即可改变的心理社会因素（如失眠、抑郁症状、幸福状况、一般健康检查状况、吸烟状况和医疗服务满意度）和不可改变的社会人口学因素（如性别、年龄、教育水平、婚姻状况、经济状况、保险拥有情况、宗教信仰、合并症和居住地点）。采用多因素逻辑回归分析，通过观察95%置信区间内的调整优势比（aOR），探讨这些因素与COPD用药知晓率之间的关系。
共识别出618例COPD患者，其中53.40%为男性。84.30%的受试者用药知晓率低。不可改变的社会人口学因素，如15 - 25岁（aOR：2.531；95% CI 1.024 - 6.253；p值0.044）、26 - 35岁（aOR：3.418；95% CI 1.444 - 8.091；p值0.005）、高中教育水平（aOR：4.870；95% CI 1.685 - 14.078；p值0.003），以及可改变的心理社会因素，如对医疗服务满意度为“足够”类别（aOR：2.510；95% CI 1.508 - 4.176；p值0.000）和吸烟的受试者（aOR：1.894；95% CI 1.147 - 3.127；p值0.013），均与COPD用药知晓率低显著相关。
本研究表明，大多数COPD患者用药知晓率低，这受到年龄、教育水平、吸烟习惯和医疗服务满意度等因素的影响。这凸显了对高危人群进行针对性干预的必要性。本研究的局限性包括依赖自我报告数据，这可能导致回忆偏差。此外，本研究无法提供因果关系的证据。
